Cao, H., Liu, F., Tan, K., Wang, Z., Huang, S., Wan, C., Huang, Y., Liu, M., Yao, Z., Li, Z., Xu, M., Zhou, H., Dai, H., Xue, S. (2025). Venetoclax, cladribine plus low-dose cytarabine for relapsed/refractory Acute Myeloid Leukemia: A multicenter, randomized phase II Study. Blood. https://doi.org/10.1182/blood-2025-5202